N2期非小细胞肺癌的治疗进展被引量：5

导出

摘要 N2期非小细胞肺癌(NSCLC)是一组异质性较大的疾病,手术、化疗、放疗、靶向治疗以及免疫治疗均被推荐用于该期患者。传统治疗方式与新型靶向治疗、免疫治疗的不同联合模式已经为N2期NSCLC患者带来显著的生存获益,但其最佳多模式联合治疗方式尚存在较大争议。

作者王雨楠曹云亮胡威

机构地区合肥医科大学第二附属医院胸部肿瘤科

出处《山东医药》 CAS 2022年第16期108-111,共4页 Shandong Medical Journal

基金贵州省卫生健康委科学技术基金项目(gzwjkj2020-1-034) 合肥医学院附属医院院基金项目(院字2015-52号)。

关键词非小细胞肺癌 N2期淋巴结转移靶向治疗免疫治疗

分类号 R734.2 [医药卫生—肿瘤]

引文网络
相关文献

参考文献3

1石鹏飞,张晓明.MVP方案新辅助化疗治疗ⅢA期非小细胞肺癌的疗效观察[J].实用癌症杂志,2016,31(5):769-771. 被引量：7
2朱晓霞,苏俊威.精确术后放疗对pⅢA-N2非小细胞肺癌患者在完全切除和辅助化疗后生存和失败模式的影响[J].循证医学,2020,20(6):325-328. 被引量：4
3王绿化,殷蔚伯.非小细胞肺癌的放射治疗进展[J].中国肿瘤,2001,10(2):93-96. 被引量：13

二级参考文献27

1章卫华,叶敏,周荣伟,孙坚.完整切除ⅢA期非小细胞肺癌术后脑转移的临床特征及危险因素分析[J].中国老年学杂志,2014,34(1):107-108. 被引量：5
2[1]Dillman RO, Hemdon J, Seagren SL, et al. Improved survival in stage Ⅲ non- small cell lung cancer: seven- year follow- up of Cancer and Leukimia Group B (CALGB) 8433 trial[J] . J Natl Cancer Inst, 1996, 88:1210 - 1215.
3[2]Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer. First analysis of a randomized trial in 353 patients[J]. J Natl Cancer Inst, 1991,83:417 - 423.
4[3]Komaki R, Scott CB, Sause WT, et al. Induction cisplatin/vinblastine and irradiation vs. Irradiation in unresectable squamous cell lung cancer: Failure paterns bv cell type in RTOG 8808/ECOG 4588[J ] . Int J Radiat Oncol Biol Phys, 1997, 39:537 - 544.
5[4]Schaake K C, van den Bogaert W, Dalesio 0, et al. Effects of concomitant cisplatin and radiation versus radiotherapy on inoperable non- small- cell lung cancer[J] . N Engl J Med,1992,326:524 - 530.
6[5]Furuse K, Fukuoka M, Kawahara M, et al.phase Ⅲ study of concunent versus sequential thoracic radiotherapy in combination withmitomycin, vinblastine and cisplatin in unresectablestage Ⅲ non - small cell lung cancer[J] .J Clin Oncol, 1999,17:2692 - 2699.
7[6]Curran W, Scott C, Langer C, et al. Phase Ⅲ comparison of sequential vs. Concurrent chemoradiation of pts with unresected stage Ⅲ non - small cell lung cancer (NSCLC) :initial report of Radiation Therapy Oncology Group (RTOG)9410.Pro. Am Soc Clin Oncol[J] .J Clin Oncol, 2000, 19(abstract 1891).
8[7]Albain K, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage Ⅲ A(N2) and Ⅲ B non - small cell lung cancer: mature results of Southwest Oncology Group phase Ⅱ study 8805 [ J]. J Clin Oncol, 1995, 13: 1880- 1892.
9[8]PORT Meta-analysis trialists Group. Postoperative radiotherapy in non-small cell lung cancer: systematic review and metaanalysis of individual patient data from nine randomized controlled trials [J]. Lancet, 1998,352: 257 - 263.
10[9]Dautzenberg B, Arriagada R, Chammard AB, et al.A controlled study of post - operative radiotherapy for completely resected non- small cell lung carcinoma[J] . Cancer, 1999, 86: 265 - 273.